Clinical Trials · NCT04404335
The Role of Anti-inflammatory Cytokines and Antimicrobial Peptide LL-37 Biomarkers in the Treatment of Periodontal Disease.
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Universidad Rey Juan Carlos
- Enrollment
- 60
- Start date
- May 2021
- Locations
- 1 site, Spain
- Primary endpoint
- LL-37 in crevicular fluid in healthy/periodontal patients.